[HTML][HTML] Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis

…, FE Mózes, ANA Jayaswal, MH Zafarmand… - Journal of …, 2021 - Elsevier
Background and Aims Vibration-controlled transient elastography (VCTE), point shear wave
elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic …

[HTML][HTML] Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual …

…, Y Oluboyede, M Breckons, H Zafarmand… - The Lancet …, 2023 - thelancet.com
Background Histologically assessed liver fibrosis stage has prognostic significance in patients
with non-alcoholic fatty liver disease (NAFLD) and is accepted as a surrogate endpoint in …

[HTML][HTML] Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

…, K Wonders, PM Bossuyt, AG Holleboom, H Zafarmand… - JHEP Reports, 2022 - Elsevier
Background & Aims Serum microRNA (miRNA) levels are known to change in non-alcoholic
fatty liver disease (NAFLD) and may serve as useful biomarkers. This study aimed to profile …

[HTML][HTML] Genetic association study of childhood aggression across raters, instruments, and age

…, K Bolhuis, T Palviainen, H Zafarmand… - Translational …, 2021 - nature.com
Childhood aggressive behavior (AGG) has a substantial heritability of around 50%. Here we
present a genome-wide association meta-analysis (GWAMA) of childhood AGG, in which all …

[HTML][HTML] Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis

…, Z Böcskei, QM Anstee, PM Bossuyt, MH Zafarmand… - Journal of …, 2020 - Elsevier
Background & Aims The enhanced liver fibrosis (ELF) test has been proposed for the non-invasive
assessment of advanced fibrosis in patients with non-alcoholic fatty liver disease (…

[HTML][HTML] Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis

…, QM Anstee, PM Bossuyt, MH Zafarmand - PLoS …, 2020 - journals.plos.org
Introduction Association between elevated cytokeratin 18 (CK-18) levels and hepatocyte
death has made circulating CK-18 a candidate biomarker to differentiate non-alcoholic fatty …

The trans-ancestral genomic architecture of glycemic traits

…, A Wong, AR Wood, T Xie, MH Zafarmand… - Nature …, 2021 - nature.com
Glycemic traits are used to diagnose and monitor type 2 diabetes and cardiometabolic health.
To date, most genetic studies of glycemic traits have focused on individuals of European …

[PDF][PDF] Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci

…, BHR Wolffenbuttel, T Young, MH Zafarmand… - The American Journal of …, 2012 - cell.com
To identify genetic factors contributing to type 2 diabetes (T2D), we performed large-scale
meta-analyses by using a custom ∼50,000 SNP genotyping array (the ITMAT-Broad-CARe …

[PDF][PDF] Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height

…, MT Lobmeyer, A Stanton, MH Zafarmand… - The American Journal of …, 2011 - cell.com
Height is a classic complex trait with common variants in a growing list of genes known to
contribute to the phenotype. Using a genecentric genotyping array targeted toward …

[HTML][HTML] Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy …

…, M Karsdal, R Ostroff, MH Zafarmand… - The Lancet …, 2023 - thelancet.com
Background The reference standard for detecting non-alcoholic steatohepatitis (NASH) and
staging fibrosis—liver biopsy—is invasive and resource intensive. Non-invasive biomarkers …